akash.verma@cenmed.com
(732) 447-1115-
T288621-50mgProduct descriptionTC-N 22A is a potent, selective, orally active and brain-permeable mGlu4 PAM with an EC50 of 9 nM in human mGlu4-expressing BHK cells. TC-N 22A is less active (EC50>:10 μM) in agonist and PAM model at mGlu 1, 2, 3, 5, and 7 -
T288621-25mgProduct descriptionTC-N 22A is a potent, selective, orally active and brain-permeable mGlu4 PAM with an EC50 of 9 nM in human mGlu4-expressing BHK cells. TC-N 22A is less active (EC50>:10 μM) in agonist and PAM model at mGlu 1, 2, 3, 5, and 7 -
T288621-10mgProduct descriptionTC-N 22A is a potent, selective, orally active and brain-permeable mGlu4 PAM with an EC50 of 9 nM in human mGlu4-expressing BHK cells. TC-N 22A is less active (EC50>:10 μM) in agonist and PAM model at mGlu 1, 2, 3, 5, and 7 -
T288621-100mgProduct descriptionTC-N 22A is a potent, selective, orally active and brain-permeable mGlu4 PAM with an EC50 of 9 nM in human mGlu4-expressing BHK cells. TC-N 22A is less active (EC50>:10 μM) in agonist and PAM model at mGlu 1, 2, 3, 5, and 7 -
T129707-5mgProduct Describtion:TIC10 (TRAIL-inducing compound 10) is a potent and stable small molecule that is orally active. It induces TRAIL transcriptionally independent of p53 and crosses the blood-brain barrier. -
T129707-50mgProduct Describtion:TIC10 (TRAIL-inducing compound 10) is a potent and stable small molecule that is orally active. It induces TRAIL transcriptionally independent of p53 and crosses the blood-brain barrier. -
T129707-25mgProduct Describtion:TIC10 (TRAIL-inducing compound 10) is a potent and stable small molecule that is orally active. It induces TRAIL transcriptionally independent of p53 and crosses the blood-brain barrier. -
T129707-10mgProduct Describtion:TIC10 (TRAIL-inducing compound 10) is a potent and stable small molecule that is orally active. It induces TRAIL transcriptionally independent of p53 and crosses the blood-brain barrier. -
T129707-100mgProduct Describtion:TIC10 (TRAIL-inducing compound 10) is a potent and stable small molecule that is orally active. It induces TRAIL transcriptionally independent of p53 and crosses the blood-brain barrier. -
S424905-1mlinhibitor of voltage-gated sodium channels: inhibitor of voltage-gated sodium channels:. -
-
S420565-1mlInformationSRT2104 (GSK2245840) is a selectiveSIRT1activator involved in the regulation of energy homeostasis. Phase 2.TargetsSIRT1In vitroSRT2104 reduces p65/RelA acetylation levels in C2C12 cells.In vivoIn male C57BL/6J mice, SRT2104 (100 mg/kg,
